{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:13:47Z","timestamp":1698556427981},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1423,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:p>Irradiated (800 rads) AKR mice received intravenous (i.v.) reconstitution with a mixture of B10.BR T\u2010depleted bone marrow cells and spleen cells. Only in groups of mice treated additionally with i.v. cyclophosphamide (Cy; 150\u2003mg\/kg), 24\u2003hr before transplantation, was long\u2010term (&gt;60% at 50 days) survival seen. In mice receiving only irradiation all animals died by 30 days post\u2010transplantation. Histological changes consistent with graft\u2010versus\u2010host disease (GVHD) were seen in the liver of reconstituted mice at 30 days, along with an organ\u2010specific increase in V\u03b23 T\u2010cell receptor\u2010positive (TCR<jats:sup>+<\/jats:sup>) cells. No such increase in V\u03b23 TCR<jats:sup>+<\/jats:sup> cells was seen in the spleen from the same mice. These data are consistent with a tissue antigen\u2010driven expansion of V\u03b23 TCR<jats:sup>+<\/jats:sup> cells associated with GVHD in the liver in this model. When we analysed cytokine production <jats:italic>in vitro<\/jats:italic> from CD3<jats:sup>+<\/jats:sup> cells restimulated with \u2018host\u2019 (AKR) antigen\u2010presenting cells (APC), we found a transition in cytokine production from preferential synthesis of type\u20101 cytokines [interleukin\u20102 (IL\u20102) and interferon\u2010\u03b3 (IFN\u2010\u03b3)] at early times (day 15) post\u2010reconsitution to increased production of type\u20102 cytokines [IL\u20104, transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2) and IL\u201010] at later times (day 30) post\u2010reconstitution in Cy\u2010treated recipients. Animals not receiving Cy did not show this \u2018switch\u2019 in cytokine production at later time points. We have observed a similar polarization in cytokine production, along with increased graft survival, in recipients of vascularized and non\u2010vascularized allografts after portal venous (p.v.), but not i.v., pretransplant donor\u2010specific immunization. We next studied AKR mice receiving 800 rads and subsequently reconsituted with B10.BR stem cells via the p.v. route. Again these mice showed prolonged survival (&gt;50% at 50 days), with polarization to IL\u20104, IL\u201010 and TGF\u2010\u03b2 on restimulation of CD3<jats:sup>+<\/jats:sup> cells <jats:italic>in vitro<\/jats:italic> at 30 days post\u2010transplant and increased V\u03b23 TCR<jats:sup>+<\/jats:sup> cells in the liver. Infusion of anti\u2010IL\u201012 monoclonal antibodies into irradiated mice receiving i.v. cell reconstitution produced a similar pattern of changes to those seen after p.v. reconstitution, while a combination of anti\u2010IL\u201010 and anti\u2010TGF\u2010\u03b2 monoclonal antibodies reversed the changes seen after p.v. reconstitution. These data are consistent with an important role for differential cytokine production in the regulation of GVHD following allogeneic bone marrow transplantation.<\/jats:p>","DOI":"10.1046\/j.1365-2567.1998.00403.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:18:19Z","timestamp":1047435499000},"page":"221-229","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of cytokine production and V\u03b2 T\u2010cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti\u2010cytokine monoclonal antibodies"],"prefix":"10.1111","volume":"93","author":[{"family":"GORCZYNSKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"ZENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"GORCZYNSKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"TERZIOGLU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"489","article-title":"Allorecognition and graft\u2010versus\u2010host disease.","volume":"15","author":"Theobald M.","year":"1995","journal-title":"Bone Marrow Trans"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.154.5.2134","article-title":"Murine minor histocompatibility antigens detected by helper T\u2003cells. Recognition of an endogenous peptide.","volume":"154","author":"Wettstein P.J.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.4049\/jimmunol.155.11.5104","article-title":"Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.","volume":"155","author":"Brochu S.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_5_2","first-page":"1198","article-title":"Comparison of helper and cytotoxic antirecipient T\u2003cell frequencies in unrelated bone marrow transplantation.","volume":"58","author":"Schwarer A.P.","year":"1994","journal-title":"Transplantation"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340501"},{"key":"e_1_2_5_7_2","first-page":"727","article-title":"Presence of host\u2010specific interleukin 2\u2010secreting T helper cell precursors correlates closely with active primary and secondary graft\u2010versus\u2010host disease.","volume":"15","author":"Bunjes D.","year":"1995","journal-title":"Bone Marrow Trans"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80004-2"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(95)80072-7"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000227326"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.155.2.585","article-title":"Polarized type 2 alloreactive CD4 (+) and CD8 (+) donor T\u2003cells fail to induce experimental acute graft\u2010versus\u2010host disease.","volume":"155","author":"Krenger W.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(91)90145-Z"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(92)90095-6"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.152.4.2011","article-title":"A role for non\u2010specific (cyclosporin A) or specific (monoclonal antibodies to ICAM\u20101, LFA\u20101 and interleukin\u201010) immunomodulation in the prolongation of skin allografts after antigen\u2010specific pre\u2010transplant immunization or transfusion.","volume":"152","author":"Gorczynski R.M.","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(95)80032-E"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00007890-199410000-00012","article-title":"Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and\/or by varying the route of allograft venous drainage.","volume":"58","author":"Gorczynski R.M.","year":"1994","journal-title":"Transplantation"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(96)80069-9"},{"key":"e_1_2_5_19_2","first-page":"27","article-title":"Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic \u03b3\u03b4+ T\u2003cells.","volume":"81","author":"Gorczynski R.M.","year":"1994","journal-title":"Cell"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90568-X"},{"key":"e_1_2_5_21_2","first-page":"139","article-title":"Liver T\u2003cell subsets and adhesion molecules in murine graft\u2010versus\u2010host disease.","volume":"16","author":"Howell C.D.","year":"1995","journal-title":"Bone Marrow Trans"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199612150-00012"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V86.6.2429.bloodjournal8662429","article-title":"Interleukin\u201012 inhibits murine graft\u2010versus\u2010host disease.","volume":"86","author":"Sykes M.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.153.9.4040","article-title":"IL\u201012 stimulates the development of acute graft\u2010vs\u2010host disease in mice that normally would develop chronic, autoimmune graft\u2010vs\u2010host disease.","volume":"153","author":"Via C.S.","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(93)90139-J"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1996.481554.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.157.2.574","article-title":"Gamma delta TCR (+) hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.","volume":"157","author":"Gorczynski R.M.","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_5_28_2","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.4049\/jimmunol.155.5.2350","article-title":"Biased liver T\u2003cell receptor V beta repertoire in a murine graft\u2010versus\u2010host disease model.","volume":"155","author":"Howell C.D.","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.150.1.197","article-title":"IL\u20102 reduces graft\u2010versus\u2010host disease and preserves a graft\u2010versus\u2010leukemia effect by selectively inhibiting CD4+ T\u2003cell activity.","volume":"150","author":"Sykes M.","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403243301206"},{"key":"e_1_2_5_31_2","first-page":"863","article-title":"Potential antileukemic effect of gamma delta T\u2003cells in acute lymphoblastic leukemia.","volume":"9","author":"Duval M.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_32_2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood.V83.4.1060.1060","article-title":"Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T\u2010cell clones.","volume":"83","author":"Van der Harst D.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood.V83.1.288.288","article-title":"Attenuation of graft\u2010versus\u2010host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T\u2003cells in an H\u20102 haplotype disparate mouse combination.","volume":"83","author":"Cavazzana\u2010Calvo M.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1182\/blood.V83.9.2560.2560","article-title":"Interleukin\u20102 inhibits graft\u2010versus\u2010host disease\u2010promoting activity of CD4+ cells while preserving CD4\u2010 and CD8\u2010mediated graft\u2010versus\u2010leukemia effects.","volume":"83","author":"Sykes M.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4049\/jimmunol.154.3.1198","article-title":"Split tolerance in spleen chimeras.","volume":"154","author":"Sprent J.","year":"1995","journal-title":"J Immunol"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.1998.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.1998.00403.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1998.00403.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T04:43:45Z","timestamp":1698468225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.1998.00403.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2567.1998.00403.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.1998.00403.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}